Scientific Committee |
Dave Brown, Vertex (UK) Chun-Wa Chung, GSK (UK) Helena Käck, Astra Zeneca (Sweden) Andreas Kuglstatter, Roche (Switzerland) Sonja Kuhn, Servier (France) Djordje Musil, Merck Healthcare KGaA (Germany) Alexey Rak, Sanofi (France) Christian Wiesmann, Novartis (Switzerland) |